Short Versus Long Intramedullary Nails in the Treatment of Proximal Femur Metastasis.

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age20+
SponsorNational Taiwan University Hospital

About this trial

The goal of this interventional randomized controlled trial is to compare the clinical outcomes in treating extremities pathological fractures (fractures of limbs caused by metastatic tumors) or impending pathological fractures with short or long intramedullary nails. The main questions it aims to answer are:

1. What is the rate of developing new distant metastasis of the operated extremities? 2. Does treating extremities (impending) pathological fractures with long intramedullary nails have lower or similar reoperation rate than the short nails? 3. Are there any differences when comparing the surgical-related complication, functional outcomes and life quality assessment between treating extremities (impending) pathological fractures with long or short intramedullary nails.

Participants who meet surgical indication will be randomized into either the long or short intramedullary nail group after informed consent. The patient will receive bone fixation with the corresponding prosthesis.

Eligibility criteria

Qualifiers

Femur (impending) pathological fracture that is suitable for intramedullary nail fixation as determined by the physician

Patient is willing to participate in this clinical trial and cooperate with follow-up

Disqualifiers

The patient has a more appropriate treatment alternative to single intramedullary nail fixation as determined by the multidisciplinary decision, such as,

The metastatic lesions involved the femur head

The metastatic lesions involved the pelvis

The metastatic lesions compromised the greater or lesser trochanter to a certain extent that arthroplasty was indicated

Trial design

Treatments tested in this trial

  • Internal fixation with short intramedullary nails
  • Internal fixation with long intramedullary nails

Treatment groups

50 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

National Taiwan University Hospital

Lead sponsor

National Taiwan University Hospital, Yun-Lin Branch

Collaborator

National Taiwan University Hospital Hsin-Chu Branch

Collaborator